SOURCE: UTEC, Inc.

November 12, 2007 06:00 ET

UTEC's Waste Destruction Division Targets On-Site Cancerous Tissue, HIV Contaminated Materials and Highly Contagious Medical Products

FOX ISLAND, WA--(Marketwire - November 12, 2007) - UTEC, Inc. (PINKSHEETS: UTEI)

Hazardous Chemicals and Biological Waste Destruction -- Update and Management's Report. The management team, headed by Dr. Fortunato Villamagna, Ph.D., CEO of UTEC, Inc., trading symbol UTEI.PK, is pleased to update its Shareholders on the Company's progress in the commercialization of the Glyd-Arc Plasma Waste Destruction Technology licensed earlier this year, and its application to the disposal of highly contagious Medical Waste, Munitions and Active Pharmaceutical Intermediates.

"The demand for safe destruction of Medical wastes, excess Munitions and waste streams generated from Specialty Chemical and Active Pharmaceutical Intermediate production represents an important growth market for UTEC," stated Dr. Villamagna.

The UTEC Plasma Oxidizer System addresses the dilemma faced by the Hospital and Medical industry with the storage and transportation of materials such as cancerous tissues, HIV contaminated materials and associated highly contagious products (bandages, wrappings, wipes, etc.) by providing a low cost, on-site solution. Hospitals and medical facilities are at special risk from these contaminants and currently medical facilities are forced to store these wastes for long periods of time or ship them at very high cost to facilities using very specialized systems. Currently used systems call for very high capital expenditure (CAPEX) for equipment yields no return on investment. The UTEC solution is ideal and will provide an inexpensive, in-house system that can easily be scaled and customized. UTEC's system can be easily installed at individual medical sites, requires little to no maintenance, operates at much lower temperatures (about 1000OC), and has no consumable components while being extremely cost effective.

UTEC -- Why UTEC is the Solution

The UTEC Waste Destruction Division will focus on providing solutions for the low-volume, high-margin processing of highly reactive, toxic and hazardous waste. UTEC's current Hazardous Chemicals and Biological Waste business strategy adds considerable strength to the company's core business. UTEC's advanced technology will provide cost effective, low CAPEX solutions through our Lease Programs at a time when medical facilities are under constant pressure to control costs. The UTEC (PINKSHEETS: UTEI) low temperature plasma system is modular and easily scalable in design. All other competing technologies are extremely large and cumbersome, typically operating at temperatures of up to 5000OC. The UTEC system functions in the 1000OC range, and can be easily insulated and installed inside current medical facilities without the higher installation costs associated with older competing technology. Further, competing systems are typically based on the decades old carbon-rod-arc processes, which have huge power needs and rods that require constant replacement. This older equipment is complex, mainly suited for large fixed sites, very capital intensive, and has high operating (power and maintenance) costs.

UTEC -- Target Market -- Potentially TONS of Medical Waste

With respect to biological wastes, UTEC does not plan to focus on generic hospital waste and trash, but instead address disposal issues facing the industry with cancerous tissues, HIV contaminated materials, highly contagious materials, and associated products (bandages, wrappings, wipes, etc.). This is not a large volume for most facilities, but disposal is expensive and involves special risks and issues, requiring very specialized systems. It is not a market where very high CAPEX cost equipment can be employed with any potential return on investment. However, it is ideal for the inexpensive in-house systems designed by UTEC, scaled and customized for individual medical facilities.

UTEC -- State of Development of our System

The UTEC system has been extensively tested and piloted, and commercial units are now in service for similar but non-medical related applications. As such, the technology has been demonstrated and proven. We currently have three lab bench models being used, and are in the process of fabricating two full-scale BETA units that will process +/-50 tons per year each. Larger scale bundles have been designed for large-scale commercial applications such as Specialty Chemicals.

UTEC -- Potential Immediate Uses

UTEC has divided the market for its Waste Destruction System into three industry groups:

--  Military Applications -- The first group includes potential customers
    in the munitions and energetic materials industry.  These customers will be
    predominantly military munitions facilities, which have demilitarization
    requirements that can no longer be met through open-air burning and open-
    air detonation of excess materials.  Both processes cause significant
    environmental problems, and UTEC now has a viable alternative to these
    processes.
    
    The munitions group includes current customer contacts from the legacy
    explosives business that UTEC has developed over the last 50 years.  UTEC
    already has key contacts, strong relationships, and paths to market with
    these customers.
    
--  Pharmaceutical Applications -- The second customer grouping consists
    of manufacturers of active pharmaceutical intermediates, who use extremely
    reactive and toxic starting materials to manufacture modern intermediates
    and drugs.  Our extensive background in chemical processing and chemical
    sales to some of these customers, and our long-term relationships with this
    industry segment provides multiple paths to this market group and gives us
    an ability to build sales.
    
--  Hospital and Medical Applications -- The third and potentially most
    profitable customer grouping will be the medical hazardous waste industry.
    UTEC's Medical Waste Destruction System can be easily installed at
    individual medical sites, requires little to no maintenance, operates at
    much lower temperatures (about 1000OC), has no consumable components, and
    is extremely cost effective. UTEC has identified this major industry
    problem that its technology can address, and will soon provide a low cost
    system in a modular and easily scalable design.  Approximately the size of
    a refrigerator, the unit will destroy cancerous tissues, HIV contaminated
    materials, highly contagious materials, and associated waste (bandages,
    wrappings, wipes, etc.) on a real time basis, on site, at costs
    considerably below current levels.
    

"Safe Harbor" Statement: Under The Private Securities Litigation Reform Act of 1995: The statements in the press release that relate to the company's expectations with regard to the future impact on the company's results from new products in development are forward-looking statements, within the meaning of the Private Securities Litigation Reform Act of 1995. Since this information may contain statements that involve risk and uncertainties and are subject to change at any time, the company's actual results may differ materially from expected results.

Compensation Disclaimer: Capital Pros Network CPN has been compensated the equivalent of $46,750 for its work with UTEI.PK. Certain oral statements made by management from time to time and certain statements contained in press releases and periodic reports issued by UTEI (the "Company"), as well as those contained herein, that are not historical facts are "forward-looking statements" within the meaning of Section 21E of the Securities and Exchange Act of 1934 and, because such statements involve risks and uncertainties, actual results may differ materially from those expressed or implied by such forward-looking statements.

Contact Information